Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 7505 - 7512 of 12099 results

Join Mintz and ML Strategies as We Kick-Off Our 21st Century Cures Act Webinar Series

January 4, 2017| Blog| Viewpoint

#MLWashingtonCyberWatch: 2017 FTC and Google Complaint

January 4, 2017| Blog| Viewpoint

Negligent Employers May Be Held Liable For a Non-Supervisory Employee's Discriminatory Actions Under “Cat’s Paw” Theory Says Second Circuit

January 3, 2017| Blog| Viewpoint

Join Us on January 12th for the Fifth Installment in Our EU General Data Protection Regulation Webinar Series

January 3, 2017| Blog| Viewpoint

Health Care Enforcement Review and 2017 Outlook: Yates Memo in Action

January 3, 2017| Blog| Viewpoint

Welcome to 2017

January 3, 2017| Blog| Viewpoint

OUTLOOK: Muni Groups Hope They Can Count on Trump's Support for Tax Exemption

January 3, 2017| News

Novel Outcome at the ITC: Patent Claims Invalidated under Alice in the 100-Day Pilot Program

January 3, 2017| News

News & Press Releases

Mintz Advises Underwriters in Assembly Biosciences' $175 Million Underwritten Offering and Concurrent Private Placement

August 18, 2025

Mintz advised the underwriters in connection with Assembly Biosciences, Inc.’s underwritten offering of an aggregate of 5,591,840 shares of common stock and pre-funded warrants to purchase up to 1,040,820 shares of common stock, together with accompanying Class A and Class B warrants to purchase up to an aggregate of 6,632,660 shares of common stock at a combined price per share of common stock and accompanying Class A warrant and Class B warrant of $19.60 and a combined price per pre-funded warrant and accompanying Class A warrant and Class B warrant of $19.599.

Mintz Advises the Underwriters in Ondas Holdings’ $173 Million Public Offering

August 18, 2025

Mintz advised the underwriters in connection with the $173 million public offering by Ondas Holdings Inc. of 53,084,000 shares of its common stock, which includes 6,924,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock.

Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE

August 15, 2025

Mintz advised the lead placement agent in connection with an up to $50 million private placement by Equillium, Inc. The PIPE was comprised of (i) an initial upfront closing of approximately $30 million in gross proceeds in exchange for approximately 52.6 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), and (ii) the potential for up to an additional $20 million in gross proceeds in exchange for up to approximately 35.1 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), subject to achieving specified milestones related to clinical study initiation and share price.

View all News and Press Releases